Johnson & Johnson (JNJ) Income Statement
JNJ 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsJNJ revenue and net income
Where JNJ's revenue goes
2025Each bar shows an amount and its share of revenue. JNJ kept 28.5% of revenue as net income.
JNJ profit margins
JNJ growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +6.0% | +5.6% | +2.7% | +3.0% |
| Gross profit | +4.2% | +4.9% | +3.4% | +2.8% |
| Operating income | +15.6% | +6.8% | +5.3% | +3.4% |
| Net income | +90.6% | +14.3% | +12.7% | +5.7% |
| EPS (diluted) | +8.1% | +2.1% | +6.1% | +5.7% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
JNJ quarterly EPS vs estimates
Johnson & Johnson beat the analyst EPS estimate in 8 of the last 8 quarters.
JNJ income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94.19B | $88.82B | $85.16B | $79.99B | $78.74B | $82.58B | $82.06B | $81.58B | $76.45B | $71.89B |
| Cost of revenue | $30.26B | $27.47B | $26.74B | $24.60B | $23.40B | $28.43B | $27.56B | $27.09B | $25.44B | $21.79B |
| Gross profit | $63.94B | $61.35B | $58.41B | $55.39B | $55.34B | $54.16B | $54.50B | $54.49B | $51.01B | $50.10B |
| Research & development | $14.66B | $17.23B | $15.05B | $14.13B | $14.28B | $12.34B | $11.36B | $10.78B | $10.59B | $9.14B |
| Sales, general & admin | $23.68B | $21.97B | $21.51B | $20.25B | $20.12B | $22.08B | $22.18B | $22.54B | $21.52B | $20.07B |
| Total operating expenses | $38.34B | $66.67B | $36.56B | $34.38B | $34.40B | $34.42B | $33.53B | $33.31B | $32.11B | $29.21B |
| Operating income | $25.60B | $22.15B | $21.85B | $21.01B | $20.94B | $19.73B | $20.97B | $21.18B | $18.90B | $20.89B |
| Interest income | $1.06B | $1.33B | $1.26B | $490.0M | $53.0M | $111.0M | $357.0M | $611.0M | $385.0M | $368.0M |
| Interest expense | $971.0M | $755.0M | $1.25B | $276.0M | $183.0M | $201.0M | $318.0M | $1.00B | $934.0M | $726.0M |
| Income before taxes | $32.58B | $16.69B | $15.06B | $19.36B | $19.18B | $16.50B | $17.33B | $18.00B | $17.67B | $19.80B |
| Income taxes | $5.78B | $2.62B | $1.74B | $2.99B | $1.38B | $1.78B | $2.21B | $2.70B | $16.37B | $3.26B |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B | $14.71B | $15.12B | $15.30B | $1.30B | $16.54B |
| EBITDA | $41.05B | $24.78B | $29.34B | $26.61B | $26.75B | $23.93B | $24.66B | $25.93B | $24.25B | $24.28B |
| EPS (diluted) | $10.80 | $9.99 | $10.43 | $10.16 | $9.80 | $8.03 | $8.68 | $8.18 | $7.30 | $6.68 |
| Gross margin | 67.9% | 69.1% | 68.6% | 69.3% | 70.3% | 65.6% | 66.4% | 66.8% | 66.7% | 69.7% |
| Operating margin | 27.2% | 24.9% | 25.7% | 26.3% | 26.6% | 23.9% | 25.6% | 26.0% | 24.7% | 29.1% |
| Net margin | 28.5% | 15.8% | 41.3% | 22.4% | 26.5% | 17.8% | 18.4% | 18.8% | 1.7% | 23.0% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.40B | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | $21.89B | $22.52B | $22.47B | $22.45B | $21.38B | $21.39B |
| Cost of revenue | $6.86B | $8.05B | $8.11B | $7.97B | $7.30B | $7.63B | $7.36B | $7.13B | $6.96B | $6.87B | $6.51B | $6.80B |
| Gross profit | $18.54B | $17.26B | $15.96B | $16.60B | $16.69B | $16.11B | $14.54B | $15.39B | $15.51B | $15.58B | $14.87B | $14.60B |
| Research & development | $4.65B | $3.65B | $3.53B | $4.25B | $3.67B | $3.52B | $3.23B | $5.30B | $4.95B | $3.44B | $3.54B | $4.48B |
| Sales, general & admin | — | $6.43B | $6.03B | $6.95B | $5.92B | $5.79B | $5.01B | $6.25B | $5.28B | $5.48B | $5.06B | $5.51B |
| Total operating expenses | $12.18B | $10.09B | $9.56B | $11.01B | $9.59B | $9.30B | $8.24B | $11.55B | $10.23B | $8.92B | $8.60B | $9.99B |
| Operating income | $6.37B | $7.17B | $6.39B | $5.59B | $7.10B | $6.81B | $6.30B | $3.84B | $5.28B | $6.66B | $6.27B | $4.61B |
| Interest income | — | $219.0M | $229.0M | $237.0M | $227.0M | $260.0M | $332.0M | $281.0M | $292.0M | $395.0M | $364.0M | $363.0M |
| Interest expense | $31.0M | $281.0M | $272.0M | $214.0M | $245.0M | $308.0M | $204.0M | $137.0M | $193.0M | $270.0M | $155.0M | $151.0M |
| Income before taxes | $34.0M | $6.75B | $5.99B | $4.97B | $7.49B | $6.49B | $13.63B | $3.89B | $3.34B | $5.75B | $3.71B | $4.83B |
| Income taxes | −$176.0M | $1.21B | $755.0M | −$150.0M | $2.34B | $954.0M | $2.63B | $456.0M | $644.0M | $1.06B | $459.0M | $694.0M |
| Net income | $210.0M | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | $11.00B | $3.43B | $2.69B | $4.69B | $3.25B | $4.05B |
| EBITDA | $6.37B | $8.99B | $8.27B | $7.19B | $9.29B | $8.74B | $15.61B | $5.92B | $5.38B | $7.80B | $5.68B | $6.82B |
| EPS (diluted) | $2.59 | $2.90 | $2.70 | $2.46 | $2.80 | $2.77 | $2.77 | $2.04 | $2.42 | $2.82 | $2.71 | $2.29 |
| Gross margin | 73.0% | 68.2% | 66.3% | 67.6% | 69.6% | 67.9% | 66.4% | 68.3% | 69.0% | 69.4% | 69.6% | 68.2% |
| Operating margin | 25.1% | 28.3% | 26.6% | 22.8% | 29.6% | 28.7% | 28.8% | 17.1% | 23.5% | 29.7% | 29.3% | 21.5% |
| Net margin | 0.8% | 21.9% | 21.8% | 20.8% | 21.5% | 23.3% | 50.2% | 15.2% | 12.0% | 20.9% | 15.2% | 18.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in JNJ's financial statements (latest annual report filed February 11, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
JNJ financial results
In fiscal year 2025 (ended December 31, 2025), Johnson & Johnson reported revenue of $94.2 billion, up 6.0% from the year before. It had net income of $26.8 billion (up 90.6%), a net profit margin of 28.5%. Diluted earnings per share came to $10.80. Over five years revenue grew at an average rate of 2.7% a year.
See the JNJ stock overview for the latest quote and news, or the JNJ chart for price history and technical indicators.
JNJ income statement FAQ
What is Johnson & Johnson's annual revenue?
Johnson & Johnson reported total revenue of $94.2 billion for fiscal year 2025, which ended on December 31, 2025. That was up 6.0% from $88.8 billion the previous year.
Is Johnson & Johnson profitable?
Yes. Johnson & Johnson reported net income of $26.8 billion in fiscal 2025, a net profit margin of 28.5%; its operating margin was 27.2%.
What is Johnson & Johnson's gross margin?
Johnson & Johnson's gross margin was 67.9% in fiscal 2025: for every $100 of revenue, Johnson & Johnson kept $68 after the direct cost of its products and services.
How much does Johnson & Johnson spend on research and development?
Johnson & Johnson spent $14.7 billion on research and development in fiscal 2025, 15.6% of revenue.
How fast is Johnson & Johnson growing?
Revenue grew 2.7% a year on average over the last five fiscal years, from $82.6 billion to $94.2 billion.
What are Johnson & Johnson's earnings per share?
Johnson & Johnson earned $10.80 per diluted share in fiscal 2025, compared with $9.99 a year earlier.
When does Johnson & Johnson's fiscal year end?
Johnson & Johnson's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 11, 2026.